ATE431162T1 - Verfahren zur inaktivierung von viren durch trockene hitze - Google Patents

Verfahren zur inaktivierung von viren durch trockene hitze

Info

Publication number
ATE431162T1
ATE431162T1 AT06847095T AT06847095T ATE431162T1 AT E431162 T1 ATE431162 T1 AT E431162T1 AT 06847095 T AT06847095 T AT 06847095T AT 06847095 T AT06847095 T AT 06847095T AT E431162 T1 ATE431162 T1 AT E431162T1
Authority
AT
Austria
Prior art keywords
inactivation
viruses
dry heat
present
transition temperature
Prior art date
Application number
AT06847095T
Other languages
German (de)
English (en)
Inventor
Annie Bardat
Original Assignee
Lab Francais Du Fractionnement
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lab Francais Du Fractionnement filed Critical Lab Francais Du Fractionnement
Application granted granted Critical
Publication of ATE431162T1 publication Critical patent/ATE431162T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT06847095T 2005-12-19 2006-12-19 Verfahren zur inaktivierung von viren durch trockene hitze ATE431162T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0512875A FR2894830B1 (fr) 2005-12-19 2005-12-19 Procede d'inactivation virale par chauffage a sec selon la temperature de transition vitreuse
PCT/FR2006/002817 WO2007071845A2 (fr) 2005-12-19 2006-12-19 Procede d'inactivation virale par chauffage a sec selon la temperature de transition vitreuse

Publications (1)

Publication Number Publication Date
ATE431162T1 true ATE431162T1 (de) 2009-05-15

Family

ID=36698885

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06847095T ATE431162T1 (de) 2005-12-19 2006-12-19 Verfahren zur inaktivierung von viren durch trockene hitze

Country Status (16)

Country Link
US (1) US8252227B2 (https=)
EP (1) EP1981549B1 (https=)
JP (1) JP5085558B2 (https=)
KR (1) KR101162060B1 (https=)
CN (1) CN101355972B (https=)
AT (1) ATE431162T1 (https=)
AU (1) AU2006328804B2 (https=)
BR (1) BRPI0621074B1 (https=)
CA (1) CA2633338C (https=)
DE (1) DE602006006875D1 (https=)
DK (1) DK1981549T3 (https=)
ES (1) ES2327279T3 (https=)
FR (1) FR2894830B1 (https=)
IL (1) IL192194A (https=)
PL (1) PL1981549T3 (https=)
WO (1) WO2007071845A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140093603A (ko) 2010-12-30 2014-07-28 라보라토이레 프란카이즈 듀 프락티온네먼트 에트 데스 바이오테크놀로지스 병원체 불활성화제로서의 글리콜
USD689039S1 (en) * 2012-07-12 2013-09-03 Alljack Co., Ltd. Stereo set
CN109444209A (zh) * 2018-10-26 2019-03-08 北京食品科学研究院 一种测量蛋清粉玻璃化转变温度的方法
CN116059410A (zh) * 2021-08-19 2023-05-05 南京金斯瑞生物科技有限公司 一种去除生物样本中噬菌体的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2248817C2 (de) * 1972-10-05 1981-09-24 Bayer Ag, 5090 Leverkusen Polycarbonatmischungen
US4456590B2 (en) * 1981-11-02 1989-05-30 Heat treatment of lyphilized blood clotting factor viii concentrate
GB9424732D0 (en) * 1994-12-08 1995-02-08 Common Services Agency Heat treated blood plasma proteins
US5837519A (en) * 1996-11-21 1998-11-17 Bayer Corporation Dry-heat viral inactivation under controlled moisture conditions
AU9775398A (en) * 1997-09-23 1999-04-12 Ib2, L.L.C. Rapid thermal cycle processing methods and apparatus
CN1286725A (zh) * 1997-11-26 2001-03-07 环球保藏技术股份有限公司 敏感性生物样品的玻化保质法
CA2347242C (en) * 1998-10-14 2008-03-25 Katrina T. Forest Method for vitrification of a biological specimen
CA2396219A1 (en) * 2000-01-04 2001-07-12 Xiangzhong Yang Oocyte vitrification technique
EP1651275A1 (en) * 2003-08-05 2006-05-03 Fuji Photo Film B.V. Use of recombinant or synthetic gelatin-like proteins as stabiliser in lyophilized pharmaceutical compositions

Also Published As

Publication number Publication date
FR2894830B1 (fr) 2008-04-04
US20090297398A1 (en) 2009-12-03
JP2009519920A (ja) 2009-05-21
ES2327279T3 (es) 2009-10-27
IL192194A0 (en) 2009-02-11
DK1981549T3 (da) 2009-08-17
BRPI0621074B1 (pt) 2016-07-26
CA2633338A1 (en) 2007-06-28
EP1981549B1 (fr) 2009-05-13
CN101355972B (zh) 2012-07-04
WO2007071845A3 (fr) 2007-08-16
KR20080093098A (ko) 2008-10-20
EP1981549A2 (fr) 2008-10-22
US8252227B2 (en) 2012-08-28
PL1981549T3 (pl) 2009-10-30
WO2007071845A2 (fr) 2007-06-28
CN101355972A (zh) 2009-01-28
DE602006006875D1 (de) 2009-06-25
AU2006328804A1 (en) 2007-06-28
CA2633338C (en) 2012-02-28
AU2006328804B2 (en) 2012-08-02
IL192194A (en) 2010-12-30
BRPI0621074A2 (pt) 2011-11-29
FR2894830A1 (fr) 2007-06-22
KR101162060B1 (ko) 2012-07-03
JP5085558B2 (ja) 2012-11-28

Similar Documents

Publication Publication Date Title
WO2009121004A3 (en) Neutralizing molecules to viral antigens
WO2008033466A3 (en) Compositions and methods for treatment of viral diseases
NZ598000A (en) Composition for treating hbv infection
ATE398672T1 (de) Immortalisierte vogelzellinien zur virusproduktion
ATE494906T1 (de) Von zellen stammende virale impfstoffe mit geringen mengen an rest-zell-dna
WO2010047830A3 (en) Agents for hcv treatment
EA201290152A1 (ru) Антисмысловые ингибиторы вируса гепатита в (hbv)
EA200870164A1 (ru) Лечение вирусного гепатита
NO20090447L (no) Hepatittt C virusinhibitorer
EA201391572A1 (ru) Модулирование экспрессии вируса гепатита в (hbv)
DK1749029T3 (da) Bindemolekyler, der kan neutralisere rabiesvirus, og anvendelser deraf
EA201000948A1 (ru) Ингибиторы вирусной полимеразы
ATE522532T1 (de) Verbindungen zur behandlung von hepatitis c
ATE494291T1 (de) Verbindungen zur behandlung von hepatitis c
EE05414B1 (et) Meetod kartuli viirushaigustest tervendamiseks ja parandatud omadustega meristeemkloonide loomiseks, viirusvaba kartuli meristeemtaim ning viirusvaba kartul
WO2009067191A3 (en) Methods and compositions for the treatment of hepatitis c virus (hcv) infection
DE502006002836D1 (de) Verfahren zur herstellung von celluloseetherprodukten mit erhöhter viskosität und feinheit
IL192194A (en) Method of viral inactivation by dry heating
EA201991751A1 (ru) Устройство и способ непрерывной сушки сыпучих продуктов, в частности древесной стружки и/или древесных волокон, с использованием многотопливной горелки с охлаждающей муфель системой
ATE505541T1 (de) Targeting von zwischenprodukten zur gegenstrangreplikation von einzelstrangigen viren durch rnai
MY169510A (en) Detection of epstein -barr virus (ebv) in nasopharyngeal cancer
EP3452595A4 (en) REAGENTS FOR THE TREATMENT OF HEPATITIS B VIRUS (HBV) INFECTION AND USE THEREOF
ATE553770T1 (de) Masernvirus-nucleoprotein zur behandlung von atherosklerose
EA201190340A1 (ru) Сухой способ обработки поверхности
ATE477807T1 (de) Verwendung einer zusammensetzung zur inhibierung vom viruspartikeln

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1981549

Country of ref document: EP